CDK8/19 inhibitor for the treatment of HER2+ breast cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA221485
- Recipient
-
Senex Biotechnology Inc. UEI G8XKMW3DYMQ6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,993
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Columbia, SC 29208, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,993 |
Quick answers
Who received award R43CA221485?
R43CA221485 was awarded to Senex Biotechnology Inc. by National Cancer Institute (National Institutes of Health) on July 1, 2017.
How much is award R43CA221485 worth?
$299,993 has been obligated on R43CA221485.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award